Gold prices dip as hawkish Fed minutes weigh ahead of Jackson Hole
Investing.com - Singular Genomics Systems (NASDAQ: OMIC) reported first quarter EPS of $-0.32, in line with the analyst estimate of $-0.32. Revenue for the quarter came in at $1.1M versus the consensus estimate of $829.67K.
Singular Genomics Systems's stock price closed at $0.55. It is up 30.98% in the last 3 months and down -58.02% in the last 12 months.
Singular Genomics Systems saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Singular Genomics Systems's stock price’s past reactions to earnings here.
According to InvestingPro, Singular Genomics Systems's Financial Health score is "weak performance".
Check out Singular Genomics Systems's recent earnings performance, and Singular Genomics Systems's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar